Special topic written talk

Relationship between high residual platelet activity and Ⅱb/Ⅲa receptor,P ⁃selectin on platelet surface prognosis in patients with non ST segment elevation acute myocardial infarction after PCI

Expand
  • Internal Medicine⁃Cardiovascular Department,Tianjin Beichen Hospital,Tianjin 300400,China

Online published: 2022-04-25

Abstract

Objective o investigate the relationship between high residual platelet activity and Ⅱb/Ⅲa receptor,P⁃selectin on platelet surface,prognosis in patients with non ST segment elevation acute myocardial infarction(NSTEMI)after percutaneous coronary intervention(PCI). Methods A total of 214 patients with NSTEMI receiving PCI were selected. According to the platelet aggregation rate,they were divided into HRPR group and LRPR group. The level of Ⅱb/Ⅲa receptor(PAC⁃1)and P⁃selectin(CD62p)on the platelet surface were measured. All patients were followed up for one year to count the occurrence of ischemic events. Results The levels of PAC⁃ 1+ /CD62P+,PAC⁃1- /CD62P+,PAC⁃1+ /CD62P- platelets in HRPR group were higher than those in LRPR group,the difference was statistically significant(P < 0.05). The platelet aggregation rate was positively correlated with the levels of PAC⁃1+ /CD62P+,PAC⁃1+ /CD62P-(P < 0.05). When platelets were pre incubated with PAC⁃1,the platelet aggregation rate was decreased significantly(P < 0.05). When platelets were pre incubated with anti⁃CD62p anti⁃ body,there was no significant change in platelet aggregation rate(P > 0.05). The incidence of ischemic events in HRPR group was higher than that in LRPR group(P < 0.05). Conclusion HRPR in NSTEMI patients after PCI was related to Ⅱb/Ⅲa receptor on platelet surface,but it′s not related to P⁃selectin. HRPR could increase the risk of ischemic events in patients.

Cite this article

LIU Jun, JIA Zhi, HUO Liwei. .

Relationship between high residual platelet activity and Ⅱb/Ⅲa receptor,P ⁃selectin on platelet surface prognosis in patients with non ST segment elevation acute myocardial infarction after PCI

[J]. The Journal of Practical Medicine, 2022 , 38(8) : 934 -937 . DOI: 10.3969/j.issn.1006⁃5725.2022.08.004

Options
Outlines

/